A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease
Clinical trial NCT03916042 · COMPLETED
Trial details
- NCT number
- NCT03916042
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-23
- Primary completion
- 2019-11-22
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.